Affymetrix and Stratagene Announce Strategic Software Alliance
announced today that they have entered into a non-exclusive strategic alliance under which Stratagene will provide Affymetrix customers with new software solutions for GeneChip(R) data analysis. As part of this agreement, Stratagene will develop a new software package for...BacterioMatch II Two-Hybrid System Vector Kit from Stratagene
Description:...Vitality pIRES-hrGFP-1 Vector from Stratagene
Description:...JM101 E. coli Strain from Stratagene
Description:...SURE E. coli Strain from Stratagene
Description:...Low Abundance cDNA Cloned Using Stratagenes Human Universal cDNA Library
Department of Cell Biology, Clevela...Stratagenes Human cDNA Microarrays: Perform Gene Expression Profiling and Discover New Genes
New GeneConnection discovery microarrays provide more than 4,000 uniquehuman cDNA sequences Stratagene introduces the first in a series of human cDNA microarrays on glass slides. These GeneConnection discovery microarrays which are based on the technology published by Schena et al., can be...Stratagene to pay Third Wave $10.75M in patent case
The case, which was litigated in U.S. District Court for the We...Stratagene sets aside $21M to pay Third Wave pending appeal
Third Wave and Stratagene have been battling since late 2004 over which company has the right to commercialize certain molecular diagnostics methods. A j...Stratagene to appeal verdict won by Third Wave
Stratagene on Saturday announced its move in response to the decision rendered last Wednesday in the United States District Court for the Western District of Wisconsin. The jury awarded Third Wave</a...